[212Pb]Pb-AG1206
/ AlphaGen Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
[212Pb]Pb-AG1206, A novel fibroblast activation protein-targeted radioligand therapy demonstrated excellent efficacy and safety profile
(AACR 2026)
- "In conclusion the data support clinical development of [212Pb]Pb-AG1206 as a novel therapeutic for patients with FAP-expressing solid tumors."
Clinical • Oncology • Solid Tumor • FAP
1 to 1
Of
1
Go to page
1